← 治験一覧に戻る
TACT-NAGOYA:細胞移植を用いた治療的血管新生
基本情報
- NCT ID
- NCT00145262
- ステータス
- 不明
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- -
- 治験依頼者名
- Nagoya University
概要
Clinical studies have established that implantation of bone marrow mononuclear cells (BM-MNCs) or peripheral blood mononuclear cells (PB-MNCs) into ischaemic limbs increases collateral vessel formation. We, the investigators at Nagoya University, further investigated the efficacy and safety of autologous implantation of BM-MNCs or PB-MNCs in patients with severe ischaemic limbs who have no other alternative therapeutic options. We also examined a potential limiting factor which reduced the efficacy of therapeutic angiogenesis using cell transplantation (TACT).
対象疾患
Buerger DiseaseArteriosclerosis Obliterans
介入
Autologous Bone Marrow Mononuclear Cell Implantation(PROCEDURE)
依頼者(Sponsor)
Nagoya University(OTHER)
実施施設 (1)
すみクリニック 内科・循環器内科・小児科
Nagoya, Japan(RECRUITING)